Pyrantel Pamoate

Verify with FDA CVM →

2,643 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,643
Total Reports
316
Deaths Reported
1200.0%
Death Rate

Active Ingredients

Pyrantel Pamoate

Administration Routes

OralUnknownTopicalSubcutaneousParenteralOphthalmicNasal

Species Affected

Dog 2,354
Cat 180
Unknown 44
Human 41
Horse 18
Other 5
Pig 1

Most Affected Breeds

Unknown 202
Crossbred Canine/dog 197
Dog (unknown) 170
Retriever - Labrador 162
Chihuahua 128
Pit Bull 123
Domestic Shorthair 102
Boxer (German Boxer) 94
Shepherd Dog - German 72
Retriever - Golden 70

Most Reported Reactions

Vomiting 740
Lethargy (see also Central nervous system depression in 'Neurological') 369
Diarrhoea 362
Anorexia 240
Death 225
Emesis 197
Depression 158
No sign 123
Lack of efficacy (endoparasite) - hookworm 121
Accidental exposure 109
Facial swelling (see also 'Skin') 107
Ataxia 101

Outcome Breakdown

Recovered/Normal
663 (31.0%)
Outcome Unknown
623 (29.2%)
Ongoing
509 (23.8%)
Died
252 (11.8%)
Euthanized
66 (3.1%)
Recovered with Sequela
23 (1.1%)

Data Summary

Metric Value
Total adverse event reports 2,643
Reports involving death 316
Case-fatality rate (reported events) 1200.0%
Distinct species in reports 7
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 2,643 adverse event reports referencing Pyrantel Pamoate, including 316 reports in which the animal died — a 1200.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Topical, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pyrantel Pamoate reports are Dog (2,354 reports), Cat (180 reports), Unknown (44 reports), with Dog accounting for the largest share. Within those species, Unknown (202), Crossbred Canine/dog (197), Dog (unknown) (170) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pyrantel Pamoate are Vomiting (740), Lethargy (see also Central nervous system depression in 'Neurological') (369), Diarrhoea (362), Anorexia (240). Of the 2,136 reports with a coded outcome, Recovered/Normal is the leading category at 31.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial